GH Research Is Taking Psychedelic 5-MeO-DMT ‘Toad Venom’ Public
GH Research is taking its psychedelic 5-MeO-DMT public on the Nasdaq with an IPO valued at more than $100 million.
GH Research is taking its psychedelic 5-MeO-DMT public on the Nasdaq with an IPO valued at more than $100 million.
Nue Life Health is a new therapy platform relying on AI and music as well as psychedelics for customized healing.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.